AGILVAX
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. The company identifies and selects lead vaccine candidates through its proprietary affinity optimizes those by in vitro and in vivo testing and develops them through pre-clinical and/or clinical testing until proof of concept is achieved establishing attractive out-licensing opportunities to Pharma or Biotech partners. Collaborations and partnerships are actively pursued within the industry, academia, and the government sector through NIAID.
AGILVAX
Industry:
Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.agilvax.com
Total Employee:
11+
Status:
Closed
Contact:
5057974531
Total Funding:
8.3 M USD
Technology used in webpage:
IPv6 Cloudflare Hosting Person Schema Gravatar Profiles Cloudflare DNS
Similar Organizations
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
Board_member
2013-11-01
Board_member
Board_member
Board_member
2013-11-01
Current Employees Featured
Joseph Patti President & CEO @ Agilvax
President & CEO
2019-08-01
David Peabody Founder @ Agilvax
Founder
Les Stewart Chief Operating Officer @ Agilvax
Chief Operating Officer
2017-02-01
Bryce Chackerian Founder @ Agilvax
Founder
Michael Perrine Director of Business Development @ Agilvax
Director of Business Development
2014-07-01
Founder
Investors List
National Cancer Institute SBIR Development Center
National Cancer Institute SBIR Development Center investment in Grant - Agilvax
National Cancer Research Institute
National Cancer Research Institute investment in Grant - Agilvax
Sun Mountain Capital
Sun Mountain Capital investment in Series A - Agilvax
J. Hunt Holdings
J. Hunt Holdings investment in Series A - Agilvax
J. Hunt Holdings
J. Hunt Holdings investment in Series A - Agilvax
Official Site Inspections
http://www.agilvax.com
- Host name: 104.21.33.39
- IP address: 104.21.33.39
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Agilvax.com lookup results from whois.dynadot.com server:
- Domain created: 14th-Jul-2011
- Domain updated: 17th-Jun-2024
- Domain expires: 14th-Jul-2025 0 Years, 91 Days left
- Website age: 13 Years, 274 Days
- Registrar Domain ID: 1666894391_DOMAIN_COM-VRSN
- Registrar Url: http://www.dynadot.com
- Registrar WHOIS Server: whois.dynadot.com
- Registrar Abuse Contact Email: abuse@dynadot.com
- Registrar Abuse Contact Phone: +16502620100
- Name server:
- ELLIOTT.NS.CLOUDFLARE.COM
- JEN.NS.CLOUDFLARE.COM
More informations about "Agilvax"
Agilvax - Crunchbase Company Profile & Funding
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. The …See details»
Agilvax, Inc. Company Profile | Albuquerque, NM | Competitors ...
Find company research, competitor information, contact details & financial data for Agilvax, Inc. of Albuquerque, NM. Get the latest business insights from Dun & Bradstreet.See details»
Agilvax Inc - Company Profile and News - Bloomberg Markets
Company profile page for Agilvax Inc including stock price, company news, executives, board members, and contact informationSee details»
Agilvax - Funding, Financials, Valuation & Investors - Crunchbase
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.See details»
Agilvax Company Profile - Office Locations, Competitors ... - Craft
AgilVax is a biotech company discovering and developing targeted antibody-based therapeutics for metastatic cancer. It offers an antibody-drug conjugate, xCT-ADC, that targets xCT …See details»
AgilVax, Inc. | St Paul, MN, USA Startup - gust.com
AgilVax® Inc. is commercializing a virus-like particle (VLP) based vaccine platform technology under a worldwide, exclusive license. The platform, derived from RNA bacteriophages, is a …See details»
Agilvax - Overview, News & Similar companies | ZoomInfo.com
Who is Agilvax. AgilVax is a biopharmaceutical company developing xCT antibody-based products to treat multiple types of cancer in combination with chemotherapy, c heckpoint and …See details»
Agilvax | Company Profile | Pharmacompass.com
Find Suppliers : API/FDF. Search Our Integrated Database ; Services. Questionnaire For Your Search - Analytical - Analytical Method Development - Biologic Drugs - Capillary …See details»
AgilVax - VentureRadar
Website: http://www.agilvax.com. Develops immunotherapy treatments using proprietary virus-like particle technology for oncology and infectious diseases, with ...See details»
Agilvax Inc. - BioCentury Company Profiles - BCIQ
Jul 26, 2019 Agilvax Inc. - BioCentury Company Profiles for the biopharma industrySee details»
AgilVax Company Overview, Contact Details & Competitors | LeadIQ
Jan 17, 2020 Agilvax hired Joseph Patti as President and Chief Executive Officer on Nov 13th '18. Agilvax, Inc. a biotechnology company developing targeted antibody-based therapeutics …See details»
Agilvax Corporate Headquarters, Office Locations and Addresses
Agilvax is headquartered in Albuquerque, 5901 Indian School Rd NE, United States, and has 2 office locations.See details»
Agilvax - Updates, News, Events, Signals & Triggers - Crunchbase
Aug 13, 2018 Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.See details»
New Mexico Startup Agilvax Moves to Phase II of SBIR Grant
May 29, 2019 As a result of the grant award, AgilVax selected a prominent Contract Manufacturing Organization (CMO) and initiated cGMP manufacturing of AX09. AX09 is being …See details»
Agilvax, Inc. | SBIR.gov
Agilvax’s AX09 is an Immunotherapy for Triple-Negative Breast Cancer: Agilvax is developing cancer immunotherapies and vaccines with its proprietary virus-like-particle (VLP) platform …See details»
Albuquerque Biotech Company Agilvax Welcomes Prestigious …
Jan 16, 2019 Local biotech company Agilvax, Inc., headquartered in Albuquerque, is commercializing a virus-like particle (VLP) technology platform, developed by researchers Dr. …See details»
AgilVax Announces Expansion of Series A-1 Financing
Jan 16, 2020 ALBUQUERQUE, N.M.--(BUSINESS WIRE)--AgilVax, Inc., a biopharmaceutical company developing targeted antibody-based products to treat multiple types of cancer in …See details»
Soligenix Announces Publication Demonstrating CiVax™ Booster …
18 hours ago COVID-19 has been declared a global pandemic by the World Health Organization. The global impact of this emerging infection demonstrates the urgent need for …See details»
Local Biotech Company Agilvax’s Cancer Immunotherapy …
Jul 10, 2018 Local start-up company Agilvax, Inc., headquartered in Albuquerque, is commercializing a virus-like particle (VLP) technology platform developed by UNM …See details»
AgilVax - Products, Competitors, Financials, Employees, …
Headquarters Location. 5901 Indian School Road North East . Albuquerque, New Mexico, 87110, United States. 505-200-9541See details»